Alnylam Pharmace. sell Biotechhunter
Start price
11.08.20
/
50%
€116.52
Target price
14.08.20
-
Performance (%)
-1.29%
End price
14.08.20
€115.02
Summary
This prediction ended on 14.08.20 with a price of €115.02. With a performance of -1.29%, the SELL prediction for Alnylam Pharmace. by Biotechhunter was down slightly. Biotechhunter has 50% into this predictionAlnylam Pharmaceuticals, Inc. (ALNY) is a biopharmaceutical company focused on the development of RNA interference (RNAi) therapeutics. Its lead drug, ONPATTRO®, is approved by the U.S. FDA for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis. The company is also developing additional RNAi therapeutic candidates for the treatment of a range of diseases, including cancer, cardiovascular disease, and viral infections. With a market capitalization of over $15 billion, Alnylam is one of the largest biotech companies in the world.
AI-generated
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Alnylam Pharmace. | 0.895% | 0.895% | -48.866% | 13.001% |
| iShares Core DAX® | 0.184% | 5.072% | 8.979% | 63.879% |
| iShares Nasdaq 100 | -0.770% | -2.079% | 26.437% | 88.094% |
| iShares Nikkei 225® | 0.733% | -3.346% | 47.887% | 78.014% |
| iShares S&P 500 | -0.166% | 0.904% | 22.974% | 69.449% |
Comments by Biotechhunter for this prediction
In the thread Alnylam Pharmace. diskutieren
Sell Alnylam Pharmace.